A new sustained-release tablet formulation of procainamide
- 1 December 1973
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 6 (4), 251-255
- https://doi.org/10.1007/bf00644741
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intermittent Intravenous Procaine Amide to Treat Ventricular ArrhythmiasAnnals of Internal Medicine, 1973
- Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.1972
- [Arrhythmia prophylaxis with procanamide: inadequate dosage?].1972
- Relation of hydralazine plasma concentration to dosage and hypotensive actionClinical Pharmacology & Therapeutics, 1972
- Metabolism of procainamide in rhesus monkey and manClinical Pharmacology & Therapeutics, 1972
- Immune Responses to Hydralazine and Nuclear Antigens in Hydralazine-Induced Lupus ErythematosusAnnals of Internal Medicine, 1972
- PHARMACOKINETICS OF PROCAINAMIDE IN MAN*Annals of the New York Academy of Sciences, 1971
- Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.1970
- Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial InfarctionNew England Journal of Medicine, 1969
- A familial study of procainamide-induced systemic lupus erythematosus: A question of pharmacogenetic polymorphismAmerican Journal Of Medicine, 1968